According to a new research study by Global Insight Services (GIS), the bioimpedance analyzers market is expected to grow rapidly over the next 10 years to reach a value of more than the US $XX billion by 2031.
Bioimpedance measuring devices are used to measure the level of fluids in living tissue. These devices use electrical conductivity and reactance, which is a property of an object that opposes any change in the electric current flowing through it. This type of device can provide vital information regarding fluid buildup or dehydration for athletes and those with chronic health conditions like heart diseases.
Request Sample Pages of this Research Report: https://www.globalinsightservices.com/request-sample/GIS10241/
Global Bioimpedance Analyzers Market: Key Drivers
Unhealthy lifestyles, such as sedentary work environments, consumption of junk food, and increased mobility automation have increased the prevalence of certain lifestyle diseases, like obesity, high blood pressure, and diabetes. According to WHO, in 2019, an estimated 38.2 million children under the age of 5 were overweight or obese. Once considered a high-income country problem, overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings. In Africa, the number of overweight children under 5 who were overweight or obese in 2019 lived in Asia. Owing to that, the increasing prevalence of lifestyle diseases is boosting the growth of the global bioimpedance analyzers market.
Likewise, emerging economies such as India, China, and Brazil are likely to see high growth in the bioimpedance analyzers market. This can be attributed to the increasing prevalence of lifestyle diseases, growing awareness about health and obesity, and infrastructural improvements in these countries. China is a prominent market in this regard, given its recent infrastructural improvements, rapid economic growth, rising domestic demand, and public-private initiatives to support healthcare research. China’s State Council approved the 2016-2020 National Fitness Plan, which has motivated all national fitness levels and increased sports participation. Due to these factors, the global bioimpedance market is witnessing significant growth opportunities.
Report Findings
The multi-frequency analyzers segment is likely to dominate the market during the forecast period
Multi-frequency bioelectrical impedance analysis (MF-BIA) may be a relatively simple, quick method to measure body composition, for instance, fat mass and fat-free mass, having the advantage of being portable, relatively cheap, and not requiring specialist training for use. The growth of this segment can be attributed to the increasing preference for multi-frequency bioimpedance analyzers is high among end-users as they are both segmental and whole-body measurements, unlike single-frequency bioimpedance analyzers.
The wired bioimpedance analyzers are likely to dominate the market during the forecast period
The key factors boosting the market growth are the increasing prevalence of lifestyle diseases coupled with initiatives by governments and private organizations to promote healthy lifestyles is boosting the growth of the segment in the market. The impedance analyzer measures the difference between the maximum current and the minimum current, but also the time difference between the potential and the current wave-forms.
The demand in the bioimpedance market for segmental body measurement is expected to grow significantly in the forecast period
The whole-body measurement is expected to hold a significant share of the market due to the increasing prevalence of obesity and metabolic disorders. Thus, the demand in the bioimpedance market would rise during the forecast period.
The demand for bioimpedance analyzers in fitness clubs and wellness centers is expected to grow significantly during the forecast period
The increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe are boosting the growth of the market.
Competitive Landscape
The global bioimpedance analyzers market report includes players such as Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare, Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., Bodystat Ltd., Maltron International, Biotekna, Withings, Biodynamics Corporation, Akern, Xiaomi, Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd., Lumsail Industrial Inc., Guangzhou Beautylife Electronic Technology Co., Ltd., Bioparhom.